Celularity (CELU)
(Delayed Data from NSDQ)
$2.98 USD
+0.22 (7.97%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.98 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About EPS Diluted (Quarterly)
The company's quarterly EPS Diluted value tell you how the company is doing this quarter. Diluted earnings per share offer a worst-case scenario -- what the company's stock would look like if the company had to immediately issue every share it had promised in stock options or convertible bonds. A company's diluted earnings per share is calculated by dividing the company's annual profit by its number of outstanding shares. A company with $1 million in profit and 1 million shares of outstanding stock has an EPS of $1.
CELU 2.98 +0.22(7.97%)
Will CELU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CELU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CELU
HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates
CELU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Akoya Biosciences (AKYA) Reports Q1 Loss, Tops Revenue Estimates
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates
Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates
Other News for CELU
Celularity to Present at H.C. Wainwright?s 26th Annual Global Investment Conference
Celularity Appoints Richard J. Berman to its Board of Directors
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Celularity receives noncompliance notification from Nasdaq
Celularity receives Nasdaq notice regarding late Form 10-Q filing